These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1635355)

  • 21. The role of plasma in the transfer of Escherichia coli cytokine-inducing substances across high-flux cellulosic membranes.
    Holmes CJ; Evans RC; Henderson LW
    J Lab Clin Med; 1994 Dec; 124(6):782-8. PubMed ID: 7798790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The past, present and future of the dialyzer.
    Mineshima M
    Contrib Nephrol; 2015; 185():8-14. PubMed ID: 26023010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Plasma Proteins on the Transport and Surface Characteristics of Polysulfone/Polyethersulfone and Asymmetric Cellulose Triacetate High Flux Dialyzers.
    Kim TR; Hadidi M; Motevalian SP; Sunohara T; Zydney AL
    Artif Organs; 2018 Nov; 42(11):1070-1077. PubMed ID: 29774568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
    Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM
    Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No evidence for endotoxin transfer across high flux polysulfone membranes.
    Bommer J; Becker KP; Urbaschek R; Ritz E; Urbaschek B
    Clin Nephrol; 1987 Jun; 27(6):278-82. PubMed ID: 3608251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro hemodialysis.
    Tielemans C; Husson C; Schurmans T; Gastaldello K; Madhoun P; Delville JP; Marchant A; Goldman M; Vanherweghem JL
    Kidney Int; 1996 Jan; 49(1):236-43. PubMed ID: 8770974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dialysis membranes on the kinetics of tumor necrosis factor-alpha production by peripheral mononuclear cells in chronic hemodialysis patients.
    Kushihata S; Yorioka N; Oda H; Ye XF; Yamakido M
    Int J Artif Organs; 1998 Jul; 21(7):384-90. PubMed ID: 9745992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrogen transfer across high- and low-flux hemodialysis membranes.
    Weber V; Linsberger I; Rossmanith E; Weber C; Falkenhagen D
    Artif Organs; 2004 Feb; 28(2):210-7. PubMed ID: 14961961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial challenge of NISSHO ultrafilter ETF 609: results of in vitro testing.
    Krautzig S; Lonnemann G; Shaldon S; Koch KM
    Artif Organs; 1996 Jul; 20(7):798-800. PubMed ID: 8828771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ex vivo flow cytometry determination of intracytoplasmic expression of IL-2, IL-6, IFN-gamma, and TNF-alpha in monocytes and T lymphocytes, in chronic hemodialysis patients.
    Rostaing L; Peres C; Tkaczuk J; Charlet JP; Bories P; Durand D; Ohayon E; de Préval C; Abbal M
    Am J Nephrol; 2000; 20(1):18-26. PubMed ID: 10644863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced cytokine induction and removal of complement products with synthetic hemodialysis membranes.
    Schindler R; Ertl T; Beck W; Lepenies J; Boenisch O; Oppermann M; Kaspar E; Frei U
    Blood Purif; 2006; 24(2):203-11. PubMed ID: 16373999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine release pathway in mononuclear cells stimulated in vitro by dialysis membranes.
    Menegatti E; Rossi D; Chiara M; Alpa M; Sena LM; Roccatello D
    Am J Nephrol; 2002; 22(5-6):509-14. PubMed ID: 12381952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of neutrophil apoptosis by uremic plasma during hemodialysis.
    Jaber BL; Balakrishnan VS; Cendoroglo MN; Perianayagam MC; King AJ; Pereira BJ
    Blood Purif; 1998; 16(6):325-35. PubMed ID: 10343079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro study of the transfer of cytokine-inducing substances across selected high-flux hemodialysis membranes.
    Evans RC; Holmes CJ
    Blood Purif; 1991; 9(2):92-101. PubMed ID: 1760147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Removal of beta-2-microglobulin by diffusion alone is feasible using highly permeable dialysis membranes.
    Naitoh A; Tatsuguchi T; Okada M; Ohmura T; Sakai K
    ASAIO Trans; 1988; 34(3):630-4. PubMed ID: 3058183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic levels of tumor necrosis factor alpha during hemodialysis with cellulosic membranes: no effect of the sterilization procedure.
    Jörres A; Safak H; Froese P; Fischer C; Müller C; Gahl GM; Vienken J
    Artif Organs; 1992 Dec; 16(6):559-63. PubMed ID: 1482324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of cytokines in hemodialysis.
    Tetta C; Camussi G; Turello E; Salomone M; Aimo G; Priolo G; Segoloni G; Vercellone A
    Blood Purif; 1990; 8(6):337-46. PubMed ID: 2093331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.